Disheartening to see some states complaining about company’s vaccine supply intentions: Bharat Biotech

By: |
May 12, 2021 4:02 PM

It is quite disheartening to listen to some states complaining about Bharat Biotech's intentions regarding supply of COVID vaccine Covaxin, a top company official said on Wednesday.

The Hyderabad-based firm is supplying Covaxin to 18 states.

It is quite disheartening to listen to some states complaining about Bharat Biotech’s intentions regarding supply of COVID vaccine Covaxin, a top company official said on Wednesday. In a tweet, Bharat Biotech Joint Managing Director Suchitra Ella said the company has already dispatched Covaxin lots to 18 states on May 10.

“18 states have been covered though in smaller shipments. Quite disheartening to the teams to hear some states complaining about our intentions. 50 of our employees are off work due to covid, yet we continue to work under pandemic lockdowns 24×7 for U,” she said in a tweet. The Hyderabad-based firm is supplying Covaxin to 18 states, including Andhra Pradesh, Haryana, Odisha, Assam, Jammu & Kashmir, Tamil Nadu, Bihar, Jharkhand and Delhi. Other states are Chhattisgarh, Karnataka, Telangana, Tripura, Madhya Pradesh, Uttar Pradesh, Gujarat, Maharashtra and West Bengal.

Earlier in the day, Delhi Deputy Chief Minister Manish Sisodia said Bharat Biotech has informed the state government that it cannot provide “additional” Covaxin doses to the national capital. The stock of Covaxin in Delhi has finished and as a result around 100 vaccination centres set up in 17 schools have been closed, he said.

“The Covaxin manufacturer has in a letter said that it cannot provide Delhi government vaccines due to unavailability, under instruction of concerned government official. It means that the central government is controlling supply of the vaccine,” Sisodia said. He also said the Centre should stop export of vaccines and share the vaccine formulae of the two manufacturers in the country with other companies for mass scale production.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid Effect: Ayurveda immunity products demand spike in Delhi, Mumbai, Bangalore during 2nd wave
2Karnataka Unlock: Mysuru only district to be under curbs; health officials send samples for genome sequencing
3Covid-19 impact: Pharma industry trends for 2021